ceriton epo 10000iu injection - Recombinant Human Erythropoietin Alfa (10000IU) medicine

Anfoe 10000IU Injection: Comprehensive Medicine Guide

No reviews yet
🏭 Sun Pharmaceutical Industries Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 23, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High
Reviewed by
SaathiMed Expert Panel | Sep 23, 2026

When to Call Your Doctor IMMEDIATELY

  • Chest pain or shortness of breath
  • Sudden weakness or numbness on one side of the body
  • Severe headache with blurred vision
  • Swelling, pain, or redness in one leg
  • Signs of allergic reaction: rash, itching, swelling of face or throat
  • Seizures
  • Sudden loss of efficacy (return of severe anemia symptoms)

If experiencing severe symptoms, call emergency services immediately.

What is ceriton epo 10000iu injection used for?

This medicine is a recombinant human erythropoietin alfa injection used to treat anemia in chronic kidney disease, chemotherapy, and HIV patients. It stimulates red blood cell production and is given intravenously by a healthcare professional.

  • Generic Name: Recombinant Human Erythropoietin Alfa
  • Manufacturer: Sun Pharmaceutical Industries Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 ceriton epo 10000iu injection के बारे में (Hindi Summary)

उपयोग: यह दवा रक्ताल्पता (एनीमिया) के इलाज के लिए इस्तेमाल की जाती है, खासकर क्रोनिक किडनी रोग, कैंसर कीमोथेरेपी, और एचआईवी संक्रमण वाले मरीजों में। यह लाल रक्त कोशिकाओं के उत्पादन को बढ़ाती है और इसे डॉक्टर द्वारा नस के माध्यम से दिया जाता है।

साइड इफेक्ट्स: आम दुष्प्रभावों में उच्च रक्तचाप, सिरदर्द, थकान, दस्त, मतली, और बुखार शामिल हैं। गंभीर दुष्प्रभावों में रक्त के थक्के बनना, दौरे, और गंभीर एलर्जी प्रतिक्रियाएं शामिल हैं।

सुरक्षा सलाह: यह दवा केवल योग्य स्वास्थ्य पेशेवर की देखरेख में ही दी जानी चाहिए। रक्तचाप, हीमोग्लोबिन, और आयरन के स्तर की नियमित निगरानी आवश्यक है। खुद से इंजेक्शन न लगाएं। यदि आपको चक्कर आना या थकान महसूस हो तो वाहन चलाने से बचें।

💡 Did You Know? The Indian pharmaceutical market is expected to reach $130 billion by 2030.

💊 ceriton epo 10000iu injection Uses & Benefits

[{"condition":"Anemia of chronic kidney disease","description":"This medicine is used to treat anemia in patients with chronic kidney disease who are not on dialysis or on dialysis, to maintain hemoglobin levels and reduce the need for blood transfusions.","evidence":"Well-established"},{"condition":"Chemotherapy-induced anemia","description":"This medicine is used to treat anemia in cancer patients receiving myelosuppressive chemotherapy, to reduce red blood cell transfusions.","evidence":"Well-established"},{"condition":"Anemia in HIV-infected patients on zidovudine","description":"This medicine is used to treat anemia associated with zidovudine therapy in HIV-positive patients.","evidence":"Well-established"},{"condition":"Anemia in surgery patients","description":"This medicine may be used to reduce the need for allogeneic blood transfusions in patients undergoing elective surgery with significant blood loss.","evidence":"Established"}]

Off-label uses: [{"condition":"Anemia in myelodysplastic syndromes","description":"Sometimes used off-label to treat anemia in patients with low-risk myelodysplastic syndromes.","evidence":"Limited"},{"condition":"Anemia of prematurity","description":"Occasionally used off-label in premature infants to reduce transfusions.","evidence":"Limited"}]

Primary treatment for: Anemia

Also treats: Chronic kidney disease, Cancer, HIV infection

📋 Drug Information

Generic Name(s)Recombinant Human Erythropoietin Alfa
Brand NameAnfoe 10000IU Injection
ManufacturerSun Pharmaceutical Industries Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassBLOOD RELATED
Action ClassErythropoiesis-stimulating agent (ESA)
Route of AdministrationIntravenous
StorageStore refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Do not shake. Protect from light. Keep in original carton until use.
Shelf Life24 months from the date of manufacture.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Ensure adequate iron stores before initiating therapy to maximize efficacy.
2
Monitor blood pressure closely, as this medicine can cause or worsen hypertension.
3
Target hemoglobin levels should be individualized; avoid exceeding 11-12 g/dL to reduce cardiovascular risk.
4
Assess for signs of thromboembolism regularly, especially in patients with cardiovascular risk factors.
5
Do not use in patients with certain cancers where ESAs may increase tumor progression.
6
Educate patients on the importance of adhering to scheduled injections and monitoring.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

Fatigue and weakness
This medicine is used to treat anemia, which causes fatigue.
Likely Use
Shortness of breath
Anemia can cause shortness of breath; this medicine may help.
Likely Use
Fever
This medicine is not a primary fever reducer.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously, so absorption is not applicable. It is directly introduced into the bloodstream.
DistributionThe volume of distribution is approximately 0.05-0.1 L/kg. It is distributed primarily in the plasma and extracellular fluid.
Protein BindingNot established from the available information.
MetabolismThe metabolism of this medicine is not fully characterized. It is believed to be metabolized via general protein catabolism pathways, similar to endogenous erythropoietin.
Half-LifeThe elimination half-life of this medicine after intravenous administration is approximately 4-13 hours in patients with chronic kidney disease, and about 4-6 hours in healthy individuals.
ExcretionExcretion is not fully established. It is likely cleared by receptor-mediated endocytosis and subsequent degradation, with some renal excretion.
BioavailabilityBioavailability is 100% for intravenous administration.
Onset of ActionReticulocyte count increases within 3-4 days; hemoglobin levels begin to rise after 2-6 weeks of therapy.
Peak Plasma TimePeak plasma concentration occurs immediately after intravenous injection.
Duration of ActionThe effect on erythropoiesis persists as long as the medicine is administered; hemoglobin levels are maintained with continued dosing.

How It Works

This medicine works by binding to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow. This binding activates intracellular signaling pathways, primarily the JAK2/STAT5 pathway, which leads to increased proliferation, differentiation, and survival of red blood cell precursors. As a result, the production of reticulocytes and mature red blood cells increases, thereby raising hemoglobin and hematocrit levels.

Mechanism Steps

1
Binding to erythropoietin receptor: This medicine binds specifically to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow.
2
Receptor dimerization and activation: Binding induces dimerization of the receptor, activating associated JAK2 kinases.
3
JAK2/STAT5 signaling: Activated JAK2 phosphorylates STAT5, which translocates to the nucleus and promotes transcription of genes involved in cell survival and proliferation.
4
Increased erythropoiesis: This leads to increased proliferation and differentiation of erythroid progenitor cells into mature red blood cells.
5
Elevated hemoglobin: The net result is an increase in red blood cell mass, hemoglobin, and hematocrit, improving tissue oxygenation.

💡 How to Take ceriton epo 10000iu injection

Strength: 10000 IU injection

1This medicine is administered by a healthcare professional intravenously.
2Do not self-administer.
3Ensure adequate iron stores before and during therapy.
4Follow your doctor's instructions for monitoring and follow-up.

Dosage Information

Adult DosageThe dose of this medicine must be individualized by a qualified clinician based on the indication, patient's age, weight, renal and hepatic function, and response to therapy. For anemia of chronic kidney disease, the typical starting dose is 50-100 IU/kg three times per week intravenously. For chemotherapy-induced anemia, the starting dose is 150 IU/kg three times per week or 40,000 IU weekly. Dose adjustments are made based on hemoglobin levels. Do not self-administer.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients may be more sensitive to the effects of this medicine. Dose selection should be cautious, reflecting the greater frequency of decreased renal, hepatic, or cardiac function. Monitor closely.
Renal ImpairmentIn patients with chronic kidney disease, the dose should be individualized based on hemoglobin levels and clinical response. Monitor renal function regularly.
Hepatic ImpairmentNo specific dosage adjustments are established for hepatic impairment. Use with caution and monitor closely.
Maximum Daily DoseNot established from the available information. Dosing is individualized.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

⏰ What to Do If You Miss a Dose

📌 Less than half the dosing interval has passed
→ Contact your healthcare provider for instructions.
💡 Do not self-administer; this medicine is given by a professional.
📌 More than half the dosing interval has passed
→ Skip the missed dose and resume the regular schedule.
💡 Do not double the dose.

⚠️ Side Effects of ceriton epo 10000iu injection

✅ Common Side Effects

Hypertension (Common (10-20%))
Monitor blood pressure regularly. If elevated, consult your doctor for management.
Headache (Common (10-15%))
Usually resolves on its own. Consult doctor if persistent or severe.
Fatigue (Common (5-10%))
Rest and maintain hydration. Report if worsening.
Diarrhea (Common (5-10%))
Stay hydrated. Consult doctor if severe or persistent.
Nausea (Common (5-10%))
Take anti-nausea measures as advised by your doctor.

🚨 Serious Side Effects

Thromboembolic events (e.g., stroke, myocardial infarction, deep vein thrombosis) (Uncommon (1-5%))
Seek immediate medical attention if you experience chest pain, shortness of breath, sudden weakness, or swelling in legs.
Pure red cell aplasia (Rare (<0.1%))
Report sudden loss of efficacy or severe anemia. Requires immediate medical evaluation.
Severe hypertension (Uncommon (1-5%))
Monitor blood pressure. Seek immediate care if severe headache, blurred vision, or chest pain occurs.
Seizures (Rare (<0.1%))
Seek emergency medical help if seizures occur.

⚠️ Rare Side Effects

Allergic reactions (anaphylaxis, angioedema)
Seek immediate medical attention if you experience rash, itching, swelling of face or throat, or difficulty breathing.
Hyperkalemia
Regular monitoring of potassium levels is advised. Report muscle weakness or irregular heartbeat.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Antihypertensives Major
Warfarin Major
Iron supplements Moderate
Cyclosporine Moderate
Androgens Minor

🚨 Major Interactions

  • Antihypertensive agents
  • Anticoagulants (e.g., warfarin)

⚡ Moderate Interactions

  • Iron supplements
  • Cyclosporine

🍷 Alcohol Interaction

Alcohol may increase the risk of hypertension and may worsen anemia. It is advisable to avoid or limit alcohol consumption while on this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Uncontrolled hypertension","Known hypersensitivity to recombinant human erythropoietin alfa or any excipient","Pure red cell aplasia","Use in patients with certain cancers where ESAs may increase tumor progression","Not for use in patients with severe cardiovascular disease"]

⚠️ Warnings & Precautions

["Increased risk of thromboembolic events; monitor closely.","May cause or worsen hypertension; monitor blood pressure.","Risk of pure red cell aplasia; monitor for loss of efficacy.","May increase risk of tumor progression in certain cancers.","Use with caution in patients with seizures.","Ensure adequate iron stores before and during therapy.","Do not use in pregnant women unless clearly needed."]

🤱 Lactation Safety

It is not known whether this medicine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when administered to a nursing woman. Consult your doctor.

💊 Overdose Management

Overdose may lead to excessive erythropoiesis, resulting in polycythemia and increased risk of thrombosis. Treatment is symptomatic and supportive. In case of overdose, seek immediate medical attention. Hemoglobin levels should be monitored and phlebotomy may be considered if necessary.

⏰ Missed Dose

If you miss a dose, contact your healthcare provider for instructions. Do not double the dose to catch up.

Additional Safety Advice

General Safety

This medicine should only be administered under the supervision of a qualified healthcare professional. Regular monitoring of blood pressure, hemoglobin, and iron levels is essential. Do not self-administer. Inform your doctor if you have a history of hypertension, seizures, or blood clots. Avoid driving or operating heavy machinery if you experience dizziness or fatigue. Report any signs of blood clots such as chest pain, shortness of breath, or swelling in the legs immediately. Do not use if you are pregnant or breastfeeding without consulting your doctor. Keep all appointments for blood tests.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to hypertension and cardiovascular events. Dose selection should be cautious, and monitoring should be frequent.

🤰 Pregnancy Planning (TTC)

This medicine is not recommended during pregnancy unless clearly needed. If you are planning pregnancy, consult your doctor to discuss risks and alternatives.

🏥 Post-Surgery Considerations

This medicine may be used to reduce the need for blood transfusions after surgery. Monitor for thromboembolic events post-operatively.

🦷 Dental Procedures

Inform your dentist that you are receiving this medicine. No specific precautions are established, but maintain good oral hygiene.

💚 Lifestyle Tips for Better Results

🏃
Follow a diet rich in iron, vitamin B12, and folate to support red blood cell production.
🥗
Monitor your blood pressure regularly at home.
😴
Stay hydrated.
💧
Avoid smoking, as it can worsen anemia and cardiovascular risk.
🧘
Engage in light exercise as tolerated to improve circulation.

🏋️ Exercise Considerations

Avoid strenuous exercise if you experience fatigue, dizziness, or shortness of breath. Consult your doctor before starting any exercise program.

🥗 Diet Recommendations

Include iron-rich foods like lean meat, beans, and spinach.
Ensure adequate vitamin C to enhance iron absorption.
Avoid excessive alcohol consumption.
Limit high-sodium foods to manage blood pressure.

💼 Impact on Daily Work & Life

This medicine may cause fatigue or dizziness; avoid driving or operating heavy machinery until you know how it affects you. It is administered in a healthcare setting, so work schedules may need adjustment for appointments.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. Stopping abruptly may lead to worsening anemia. Your doctor will determine when to discontinue based on your hemoglobin levels and clinical response.

📅 Long-Term Use Effects

Long-term use of this medicine may increase the risk of cardiovascular events, thromboembolism, and hypertension. Regular monitoring of hemoglobin, blood pressure, and iron status is required. The dose should be adjusted to maintain the lowest hemoglobin level sufficient to avoid transfusions. Long-term use in certain cancers may increase the risk of tumor progression.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Iron supplementation

Correcting iron deficiency can improve anemia and may reduce the need for this medicine.

Evidence: Well-established
Blood transfusion

Used for severe anemia when rapid correction is needed.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

No specific interactions with vaccines are established. However, consult your doctor before receiving any live vaccines while on this medicine.

📦 Storage Guide

✅ DO

Store refrigerated at 2°C to 8°C

❌ DON'T

Do not freeze

✅ DO

Keep in original carton to protect from light

❌ DON'T

Do not shake

✅ DO

Use before expiry date

❌ DON'T

Do not use if discolored or contains particles

✈️ Traveling with This Medicine

Carry this medicine in its original packaging with a copy of your prescription. Store it in a refrigerated container or cooler bag during travel. Do not freeze. Inform airport security about the medication and any needles or syringes. Plan for time zone adjustments if your dosing schedule is affected. Check customs regulations for importing prescription medications.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old man with chronic kidney disease on dialysis
He was started on this medicine intravenously three times a week. After 4 weeks, his hemoglobin improved from 8.5 to 10.5 g/dL, and he reported less fatigue and improved appetite. He required close monitoring of blood pressure, which was managed with medication.
💡 Lesson: Regular monitoring and adherence to the injection schedule are key to improving anemia symptoms and quality of life.
👤 A 45-year-old woman undergoing chemotherapy for breast cancer
She received this medicine weekly to manage chemotherapy-induced anemia. Her hemoglobin stabilized, reducing the need for blood transfusions. She experienced mild headache and fatigue, which resolved with rest and hydration.
💡 Lesson: This medicine can effectively reduce transfusion requirements in chemotherapy patients, but side effects should be managed promptly.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: Reticulocyte counts increase within 3-4 days, but hemoglobin levels typically rise after 2-6 weeks of therapy.

Q: How is this medicine administered?

A: It is given intravenously by a healthcare professional.

Q: What are the serious side effects?

A: Serious side effects include blood clots, severe hypertension, seizures, and pure red cell aplasia.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?

🔄 Substitutes for ceriton epo 10000iu injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine can be self-administered at home.
    Fact: This medicine must be administered by a healthcare professional intravenously.
  • Myth: This medicine is a cure for anemia.
    Fact: This medicine treats anemia by stimulating red blood cell production but does not cure the underlying cause.

🔄 Alternative Options

Generic Alternatives

  • Recombinant human erythropoietin alfa

Brand Alternatives

  • Eprex
  • Epogen
  • Procrit
  • Binocrit
  • Retacrit

📊 Comparison with Similar Medicines

[{"medicine":"This medicine","active_ingredient":"Recombinant human erythropoietin alfa","route":"Intravenous","frequency":"Three times weekly or weekly","notes":"Short-acting ESA"},{"medicine":"Darbepoetin alfa","active_ingredient":"Darbepoetin alfa","route":"Intravenous or subcutaneous","frequency":"Weekly or every 2 weeks","notes":"Long-acting ESA"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory